Disability and HIV: Vulnerability of People With Disabilities to HIV Infection in Sub-Saharan Africa (HandiVIH)
Disability and HIV: an Appraisal of the Vulnerability of People With Disabilities to HIV Infection in Two Main Cities of Sub-Saharan Africa
Sponsor: ANRS, Emerging Infectious Diseases
This observational or N/A phase trial investigates Disability and HIV and is currently completed. ANRS, Emerging Infectious Diseases leads this study, which shows 9 recorded versions since 2014 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Oct 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Oct 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Sep 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Nov 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ANRS, Emerging Infectious Diseases
- Centre de Recherche Internationale pour la Santé de l'Université de Ouagadougou
- Forum Camerounais de Psychologie
- Handicap International
- Institut de Formation et de Recherche Démographique
- Institut de Recherche pour le Developpement
For direct contact, visit the study record on ClinicalTrials.gov .